You have read all your free articles, to continue reading subscribe to read the rest of this content.
Immunovia, Inc has received final approval to begin patient testing for the IMMray PanCan-d test. The IMMray PanCan-d test is the first blood test on the market dedicated to the early detection of pancreatic cancer. “We are extremely pleased to have achieved this important milestone and to bAlready a subscriber…
Orion Corporation has received favorable pharmacokinetic study results with combined salmeterol-fluticasone formulation of the Easyhaler product family and based on the results Orion is planning to apply for a marketing authorisation for the product in Europe. Orion currently estimates that the mAlready a subscriber Login You have read all your…
AstraZeneca Pharmaceutical’s naloxegol or Moventig, is now available on the Swedish market, the first country in Europe since approval for the European market was granted in 2014. In mid- September 2014, naloxgel was approved for use in the U.S. under the name Movantik. It was launched on the UAlready a…
AstraZeneca and Amgen’s Tezspire has been approved in the US for the add-on maintenance treatment of adult and paediatric patients aged 12 years and older with severe asthma. Tezspire was approved following a Priority Reviewby the US Food and Drug Administration (FDA) and based on results from Already a subscriber…
